Bridgeway Capital Management »

Omega Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Omega Therapeutics (OMGAQ) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Omega Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Omega Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omega Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $48k 64k 0.75
2024-09-30 $145k 119k 1.22
2024-06-30 $246k 119k 2.07
2024-03-31 $526k 144k 3.65

More positions owned by Bridgeway Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Apple (AAPL)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Wells Fargo & Company (WFC)
Palantir Technologies Cl A (PLTR)
Signet Jewelers SHS (SIG)
Amazon (AMZN)
Merck & Co (MRK)
Tutor Perini Corporation (TPC)
Verizon Communications (VZ)

View all positions for Bridgeway Capital Management

Top funds holding Omega Therapeutics

Huntington National Bank

View all funds holding Omega Therapeutics